Redesigned proficiency testing materials improve for prostate-specific antigen

A College of American Pathologists ligand assay survey study

L. J. Sokoll, D. L. Witte, G. G. Klee, D. W. Chan

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Context. - Large disparities in prostate-specific antigen (PSA) results from different assays have been observed in the College of American Pathologists (CAP) Ligand Assay Survey, with interassay results varying severalfold. Survey specimens are predominately composed of free PSA and do not reflect the composition of typical patient specimens. Objectives. - To characterize a pilot material developed for CAP in which pooled sera samples were spiked with purified PSA and α1-antichymotrypsin-bound PSA at targeted concentrations and to compare it to CAP survey and reference materials. Design. - CAP survey, reference, and pilot materials were analyzed using 10 total PSA and 7 free PSA assays. These assays included Food and Drug Administration-approved assays and assays for research use only. Results. - Variability among the 10 total PSA methods was greatest for the 1997 ligand survey material (CV range, 56%-65%) followed by the pilot material (CV range, 10%-29%) and the reference material (CV range, 6%-13%). In contrast, interassay variability for the 7 free PSA methods was similar for the 3 preparations, with the exception of one specimen close to the limit of detection of the assays. As determined with the Hybritech Tandem-R method, the ligand survey specimens were essentially composed of all free PSA, whereas the reference and pilot materials were composed of approximately 10% and 35% free PSA, respectively. Conclusions. - The newly formulated pilot material prepared using a human base that contained defined concentrations of free PSA and α1-antichymotrypsin-bound PSA more closely resembled patient specimens and minimized differences among methods compared with the semen-supplemented original survey material.

Original languageEnglish (US)
Pages (from-to)1608-1613
Number of pages6
JournalArchives of Pathology and Laboratory Medicine
Volume124
Issue number11
StatePublished - 2000
Externally publishedYes

Fingerprint

Materials Testing
Prostate-Specific Antigen
Ligands
Surveys and Questionnaires
Pathologists
United States Food and Drug Administration
Semen
Limit of Detection

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Redesigned proficiency testing materials improve for prostate-specific antigen : A College of American Pathologists ligand assay survey study. / Sokoll, L. J.; Witte, D. L.; Klee, G. G.; Chan, D. W.

In: Archives of Pathology and Laboratory Medicine, Vol. 124, No. 11, 2000, p. 1608-1613.

Research output: Contribution to journalArticle

@article{3cdf880b895d42f38ab7f7cfe8fd5671,
title = "Redesigned proficiency testing materials improve for prostate-specific antigen: A College of American Pathologists ligand assay survey study",
abstract = "Context. - Large disparities in prostate-specific antigen (PSA) results from different assays have been observed in the College of American Pathologists (CAP) Ligand Assay Survey, with interassay results varying severalfold. Survey specimens are predominately composed of free PSA and do not reflect the composition of typical patient specimens. Objectives. - To characterize a pilot material developed for CAP in which pooled sera samples were spiked with purified PSA and α1-antichymotrypsin-bound PSA at targeted concentrations and to compare it to CAP survey and reference materials. Design. - CAP survey, reference, and pilot materials were analyzed using 10 total PSA and 7 free PSA assays. These assays included Food and Drug Administration-approved assays and assays for research use only. Results. - Variability among the 10 total PSA methods was greatest for the 1997 ligand survey material (CV range, 56{\%}-65{\%}) followed by the pilot material (CV range, 10{\%}-29{\%}) and the reference material (CV range, 6{\%}-13{\%}). In contrast, interassay variability for the 7 free PSA methods was similar for the 3 preparations, with the exception of one specimen close to the limit of detection of the assays. As determined with the Hybritech Tandem-R method, the ligand survey specimens were essentially composed of all free PSA, whereas the reference and pilot materials were composed of approximately 10{\%} and 35{\%} free PSA, respectively. Conclusions. - The newly formulated pilot material prepared using a human base that contained defined concentrations of free PSA and α1-antichymotrypsin-bound PSA more closely resembled patient specimens and minimized differences among methods compared with the semen-supplemented original survey material.",
author = "Sokoll, {L. J.} and Witte, {D. L.} and Klee, {G. G.} and Chan, {D. W.}",
year = "2000",
language = "English (US)",
volume = "124",
pages = "1608--1613",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "11",

}

TY - JOUR

T1 - Redesigned proficiency testing materials improve for prostate-specific antigen

T2 - A College of American Pathologists ligand assay survey study

AU - Sokoll, L. J.

AU - Witte, D. L.

AU - Klee, G. G.

AU - Chan, D. W.

PY - 2000

Y1 - 2000

N2 - Context. - Large disparities in prostate-specific antigen (PSA) results from different assays have been observed in the College of American Pathologists (CAP) Ligand Assay Survey, with interassay results varying severalfold. Survey specimens are predominately composed of free PSA and do not reflect the composition of typical patient specimens. Objectives. - To characterize a pilot material developed for CAP in which pooled sera samples were spiked with purified PSA and α1-antichymotrypsin-bound PSA at targeted concentrations and to compare it to CAP survey and reference materials. Design. - CAP survey, reference, and pilot materials were analyzed using 10 total PSA and 7 free PSA assays. These assays included Food and Drug Administration-approved assays and assays for research use only. Results. - Variability among the 10 total PSA methods was greatest for the 1997 ligand survey material (CV range, 56%-65%) followed by the pilot material (CV range, 10%-29%) and the reference material (CV range, 6%-13%). In contrast, interassay variability for the 7 free PSA methods was similar for the 3 preparations, with the exception of one specimen close to the limit of detection of the assays. As determined with the Hybritech Tandem-R method, the ligand survey specimens were essentially composed of all free PSA, whereas the reference and pilot materials were composed of approximately 10% and 35% free PSA, respectively. Conclusions. - The newly formulated pilot material prepared using a human base that contained defined concentrations of free PSA and α1-antichymotrypsin-bound PSA more closely resembled patient specimens and minimized differences among methods compared with the semen-supplemented original survey material.

AB - Context. - Large disparities in prostate-specific antigen (PSA) results from different assays have been observed in the College of American Pathologists (CAP) Ligand Assay Survey, with interassay results varying severalfold. Survey specimens are predominately composed of free PSA and do not reflect the composition of typical patient specimens. Objectives. - To characterize a pilot material developed for CAP in which pooled sera samples were spiked with purified PSA and α1-antichymotrypsin-bound PSA at targeted concentrations and to compare it to CAP survey and reference materials. Design. - CAP survey, reference, and pilot materials were analyzed using 10 total PSA and 7 free PSA assays. These assays included Food and Drug Administration-approved assays and assays for research use only. Results. - Variability among the 10 total PSA methods was greatest for the 1997 ligand survey material (CV range, 56%-65%) followed by the pilot material (CV range, 10%-29%) and the reference material (CV range, 6%-13%). In contrast, interassay variability for the 7 free PSA methods was similar for the 3 preparations, with the exception of one specimen close to the limit of detection of the assays. As determined with the Hybritech Tandem-R method, the ligand survey specimens were essentially composed of all free PSA, whereas the reference and pilot materials were composed of approximately 10% and 35% free PSA, respectively. Conclusions. - The newly formulated pilot material prepared using a human base that contained defined concentrations of free PSA and α1-antichymotrypsin-bound PSA more closely resembled patient specimens and minimized differences among methods compared with the semen-supplemented original survey material.

UR - http://www.scopus.com/inward/record.url?scp=0033730794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033730794&partnerID=8YFLogxK

M3 - Article

VL - 124

SP - 1608

EP - 1613

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 11

ER -